Takeda Pharmaceutical Co (JP:4502) has released an update.
Takeda Pharmaceutical Co. emphasizes its dedication to enhancing corporate governance by strengthening internal controls, compliance, and risk management for transparent and agile decision-making. Compliant with the Corporate Governance Code, the company aims to secure shareholder rights, ensure equal treatment, and foster cooperation with stakeholders. Takeda also focuses on promoting Diversity, Equity, and Inclusion (DE&I) across its global workforce, with 43% of management positions held by women globally as of March 31, 2024.
For further insights into JP:4502 stock, check out TipRanks’ Stock Analysis page.
